This list is based on the watchlists of people on Stock Events who follow 6XY.MU. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
HBM Holdings Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of antibody therapeutics focusing on immunology and oncology in Mainland China, the United States, Europe, and internationally. It develops the Harbour Mice Platform, which generates human monoclonal antibodies in two heavy and two light chain H2L2 and heavy chain formats. The company is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds and inhibits the neonatal fragment crystallizable receptor for treating myasthenia gravis; Porustobart HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4 for treating melanoma, colorectal cancer, hepatocellular carcinoma, and neuroendocrine neoplasm. It is also developing HBM7020 for treating hematologic carcinoma and autoimmune diseases; HBM9378 for the treatment of asthma and chronic obstructive pulmonary disease; and HBM1020, HBM1022, HBM9014, HBM7022, HBM7008, HBM9027, HBM7004, and HBM9033 for treating solid tumors. The company has a strategic collaboration with Evinova to apply AI and digital technologies to enhance the efficiency of biologics development. The company was incorporated in 2016 and is based in Suzhou, the People's Republic of China.
The current price of 6XY.MU is €1.44 EUR — it has decreased by -0.69% in the past 24 hours. Watch HBM Limited stock price performance more closely on the chart.
What is HBM Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange HBM Limited stocks are traded under the ticker 6XY.MU.
When is the next HBM Limited earnings date?▼
HBM Limited is going to release the next earnings report on September 02, 2026.
What were HBM Limited earnings last quarter?▼
6XY.MU earnings for the last quarter are 0.08 EUR per share, whereas the estimation was N/A EUR resulting in a N/A surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does HBM Limited have?▼
As of May 05, 2026, the company has 272 employees.
In which sector is HBM Limited located?▼
HBM Limited operates in the Health & Wellness sector.
When did HBM Limited complete a stock split?▼
HBM Limited has not had any recent stock splits.
Where is HBM Limited headquartered?▼
HBM Limited is headquartered in Suzhou, Cayman Islands.